In the context of neurodegenerative disorders such as Alzheimer’s disease (AD), the upregulated activity of GSK3α has been found to be involved in the proteolysis processing of the Aβ peptide precursor in its toxic forms of Aβ40 and Aβ42 [32,33]. The gene discussed is GSK3A; the disease is Alzheimer disease.